Blueshift Asset Management’s Outset Medical OM Stock Holding History

Blueshift Asset Management’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-393	Closed	-$268K	–	921
2022 Q1	$268K	Buy	393 +36	+10%	+$21.7K	0.02%	649
2021 Q4	$247K	Hold	357	–	–	0.02%	695
2021 Q3	$265K	Buy	+357	New	+$243K	0.01%	861
2021 Q2	–	Sell	-454	Closed	-$370K	–	1097
2021 Q1	$370K	Buy	+454	New	+$350K	0.04%	577

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Blueshift Asset Management's OM Position: Q2 2022 in Review

Blueshift Asset Management sold out of Outset Medical (OM) in Q2 2022, closing a stake of 393 shares — an estimated $268K sold.

Blueshift Asset Management first reported a position in OM in Q1 2021 and held it in 4 quarters. The position peaked at $370K in Q1 2021. 149 funds tracked by Wall St. Rank hold OM as of Q2 2022.

Blueshift Asset Management reported no remaining Outset Medical position as of Q2 2022 after selling out during the quarter.
Blueshift Asset Management sold 393 Outset Medical shares in Q2 2022, an estimated $268K.
Blueshift Asset Management first reported a position in Outset Medical in Q1 2021 and held it in 4 quarters.
Blueshift Asset Management's Outset Medical position peaked at $370K in Q1 2021.
149 funds tracked by Wall St. Rank held Outset Medical as of Q2 2022.

Based on Blueshift Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.